Peter Sondermann

Company: Tacalyx GmbH

Job title: Chief Executive Officer

Seminars:

Diving Into FcR Receptor Biology to Unlock The Potential for Diverse Therapeutic Applications in Cancer & Autoimmune Disease 9:30 am

Deepen your understanding of the intricate interplay between Fc receptors and their ligands, gaining critical insights into the fundamental biology that drives therapeutic efficacy and unlocks new avenues for precision medicine. This workshop will focus on: Differentiating the functional roles of various Fc receptors, to understand their distinct signalling pathways and effector functions to enable…Read more

day: Pre-Conference Day